Literature DB >> 20488815

Resting myocardial blood flow, coronary flow reserve, and contractile reserve in hibernating myocardium: implications for using resting myocardial contrast echocardiography vs. dobutamine echocardiography for the detection of hibernating myocardium.

Michael Hickman1, Rajesh Chelliah, Leah Burden, Roxy Senior.   

Abstract

AIMS: Controversy exists regarding the relative status of resting myocardial blood flow (MBF), coronary flow reserve (CFR), and contractile reserve (CR) in hibernating myocardium (HM). We hypothesized that CFR is more profoundly affected than resting MBF parameters in HM. Thus, resting MBF assessed by myocardial contrast echocardiography (MCE) will be more sensitive than CR elicited by dobutamine stress echocardiography (DSE) for the detection of HM. METHODS AND
RESULTS: Accordingly 27 patients with ischaemic cardiomyopathy underwent resting MCE and DSE prior to revascularisation, of which 23 patients underwent follow-up echocardiography at 179 ± 66 days after revascularization. Qualitative and quantitative MCE [contrast intensity (A, dB)], MBF (represented by blood velocity β, dB/s), and CFR (vasodilator β/rest β, β reserve) were obtained. CR was obtained during DSE. Resting contrast intensity (7.2 ± 2.3 dB) and β (0.67 ± 0.47 dB/s) were significantly (P < 0.005 and <0.01, respectively) reduced in HM vs. remote normal myocardium but significantly higher compared with non-viable segments (4.4 ± 2.3 dB and 0.43 ± 0.32 dB/s, respectively). However, CFR was significantly (0.82 ± 3.2 (P = 0.01)) lower in HM compared with normal (1.8 ± 1.02) but not significantly reduced when compared with non-viable myocardium (1.1 ± 3.3). Sensitivity for the detection of HM with qualitative and quantitative MCE were 82 and 87%, respectively, compared with 67% (P < 0.0001) by DSE with similar specificity of 55 and 67%, respectively, compared with 63% with DSE.
CONCLUSION: Resting MBF but not CFR distinguished HM from non-viable myocardium. Resting MCE and not DSE was more accurate for the prediction of HM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488815     DOI: 10.1093/ejechocard/jeq062

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  5 in total

Review 1.  Multimodality Imaging of Myocardial Viability.

Authors:  Kinjan Parikh; Alana Choy-Shan; Munir Ghesani; Robert Donnino
Journal:  Curr Cardiol Rep       Date:  2021-01-04       Impact factor: 2.931

Review 2.  Contrast echocardiography for detection of myocardial perfusion abnormalities : A clinical perspective.

Authors:  N Karogiannis; R Senior
Journal:  Herz       Date:  2017-05       Impact factor: 1.443

Review 3.  Could 13C MRI assist clinical decision-making for patients with heart disease?

Authors:  Craig R Malloy; Matthew E Merritt; A Dean Sherry
Journal:  NMR Biomed       Date:  2011-05-24       Impact factor: 4.044

Review 4.  The benefits of revascularization in chronic heart failure.

Authors:  Sothinathan Gurunathan; Asrar Ahmed; Roxy Senior
Journal:  Curr Heart Fail Rep       Date:  2015-04

5.  The myocardial ischemia evaluated by real-time contrast echocardiography may predict the response to cardiac resynchronization therapy: a large animal study.

Authors:  Yongle Chen; Leilei Cheng; Haohua Yao; Haiyan Chen; Yongshi Wang; Weipeng Zhao; Cuizhen Pan; Xianhong Shu
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.